Nuveen’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.06M Buy
173,524
+12,186
+8% +$221K ﹤0.01% 1970
2025
Q4
$2.29M Sell
161,338
-74,560
-32% -$1.41M ﹤0.01% 2233
2025
Q3
$5.84M Buy
235,898
+10,509
+5% +$234K ﹤0.01% 1834
2025
Q2
$5.11M Sell
225,389
-461,518
-67% -$10.9M ﹤0.01% 1868
2025
Q1
$20.8M Buy
686,907
+126,270
+23% +$4.81M 0.01% 1113
2024
Q4
$22.2M Buy
560,637
+181,676
+48% +$8.19M 0.01% 1125
2024
Q3
$24M Sell
378,961
-57,391
-13% -$4.14M 0.01% 1067
2024
Q2
$29.5M Buy
436,352
+20,378
+5% +$1.42M 0.01% 883
2024
Q1
$32.9M Sell
415,974
-39,015
-9% -$3.19M 0.01% 858
2023
Q4
$35.4M Buy
454,989
+5,863
+1% +$434K 0.01% 788
2023
Q3
$31.6M Buy
449,126
+18,001
+4% +$1.34M 0.01% 772
2023
Q2
$34.3M Buy
431,125
+3,043
+0.7% +$220K 0.01% 743
2023
Q1
$30.9M Buy
428,082
+19,980
+5% +$1.56M 0.01% 777
2022
Q4
$33.6M Sell
408,102
-297,028
-42% -$24.5M 0.01% 727
2022
Q3
$55.1M Buy
705,130
+67,761
+11% +$5.42M 0.02% 497
2022
Q2
$43.1M Sell
637,369
-37,747
-6% -$2.63M 0.02% 611
2022
Q1
$44M Sell
675,116
-28,877
-4% -$1.68M 0.01% 698
2021
Q4
$42.7M Buy
703,993
+140,304
+25% +$8.37M 0.01% 763
2021
Q3
$36M Buy
563,689
+101,735
+22% +$6.42M 0.01% 869
2021
Q2
$29M Buy
461,954
+61,956
+15% +$3.89M 0.01% 1092
2021
Q1
$22.9M Buy
399,998
+660
+0.2% +$35.7K 0.01% 1216
2020
Q4
$20.1M Buy
399,338
+117,414
+42% +$4.68M 0.01% 1266
2020
Q3
$8.31M Sell
281,924
-3,508
-1% -$102K ﹤0.01% 1629
2020
Q2
$7.17M Sell
285,432
-26,054
-8% -$650K ﹤0.01% 1699
2020
Q1
$5.72M Buy
311,486
+87,489
+39% +$2.5M ﹤0.01% 1636
2019
Q4
$7.44M Sell
223,997
-13,694
-6% -$429K ﹤0.01% 1759
2019
Q3
$7.39M Sell
237,691
-5,738
-2% -$175K ﹤0.01% 1747
2019
Q2
$8.51M Buy
+243,429
New +$7.87M ﹤0.01% 1703
2017
Q4
Sell
-190,105
Closed -$9.08M 1083
2017
Q3
$9.08M Buy
+190,105
New +$9.27M 0.06% 411
2017
Q1
Sell
-247,269
Closed -$8.19M 1366
2016
Q4
$8.19M Buy
247,269
+24,556
+11% +$953K 0.04% 515
2016
Q3
$11M Sell
222,713
-6,716
-3% -$350K 0.06% 362
2016
Q2
$12.7M Buy
229,429
+33,451
+17% +$1.96M 0.08% 309
2016
Q1
$10.8K Buy
195,978
+191,017
+3,850% +$10.9M 0.06% 322
2015
Q4
$293 Buy
4,961
+1,350
+37% +$87.9K ﹤0.01% 1375
2015
Q3
$239 Buy
+3,611
New +$278K ﹤0.01% 1457
2015
Q2
Sell
-5,601
Closed -$401K 1597
2015
Q1
$401K Hold
5,601
﹤0.01% 1403
2014
Q4
$343K Sell
5,601
-79
-1% -$4.6K ﹤0.01% 1447
2014
Q3
$275K Buy
+5,680
New +$278K ﹤0.01% 1459

Other funds holding ACHC

Nuveen's ACHC Position: Q1 2026 in Review

Nuveen increased its Acadia Healthcare (ACHC) stake by 7.6% in Q1 2026, buying an estimated $221K and bringing the position to 173,524 shares worth $4.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1970.

Nuveen first reported a position in ACHC in Q3 2014 and has held it in 38 quarters since. The position peaked at $55.1M in Q3 2022. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Nuveen held 173,524 shares of Acadia Healthcare worth $4.06M as of Q1 2026.
  • Nuveen bought 12,186 Acadia Healthcare shares in Q1 2026, an estimated $221K.
  • Acadia Healthcare made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #1970 holding.
  • Nuveen first reported a position in Acadia Healthcare in Q3 2014 and has held it in 38 quarters since.
  • Nuveen's Acadia Healthcare position peaked at $55.1M in Q3 2022.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.